Member Info for DeAar

Yes, like news of another mAb deal. Oh wait, those aren't good enough for some....

I don't think the panel convened around the poster.

After mentioning the panel and their recommendation, the RNS states - "A poster, presenting the first stage of the SCOPE study, was also very well received at ASCO with Prof Durrant, Dr Heather Shaw, Dr Robert Miller and Mr Fayaz Master discussing the results for three hours with oncologists, pharmaceutical companies and commercial enterprises."

Don't bother.

The weekly and monthly charts look fantastic for a breakout.

A Sangoma is a Southern African traditional healer (witchdoctor to some). The "medicine" they give is called "muti".

I suspect labrow is familiar with them.

I never knew Lindy was a Sangoma!

Maybe my eyes don't see all the zero's or see too many (or im just barking up the wrong tree!). GF's post was 50000 and what I think was a buy, was for 500000?

WIP well informed! What are you on about? He was a complete fraud. Kept saying GSK were definitely going to take on SRA737 and progress it and ramp, ramp, ramp. Then GSK handed it back and WIP disappeared.

Why would Calculus sell? Well, because they manage two funds (similar to an ETF) and if investors withdraw their capital from those funds then Calculus have to sell shares to pay the investors their money back.

Seeing the SP drop consistently today while there are mostly buys makes me think there will be another black trade at the end of the day. The seller is not done but is managing the sells very carefully. I agree with C7 that it could be Calculus. I've messaged Scancell to see if they can provide an up to date holding for Calculus as the website only shows their holding as of 15th January 2024.

Once the seller stops this will finally start climbing gradually.

That's one serious superiority complex you have there Mafuta. Not a great trait.....

Can be used to label the pages of trials. There is no error in the Edison report.

He was on about Making Antibodies Great Again. They are wonderful things, beautiful things. Better than disinfectant.

Https://x.com/NottmBRCLung/status/1803377235111329883?t=v2zj_SEjKJKUO1VukG4lUA&s=19

They probably bought when the price was higher and expected to make a quick buck. The RNS they want hasn't come quickly enough and they are down big on paper. Now they look to blame someone - the respected poster (whom they probably agreed with in the beginning) and the CEO are prime candidates. They just can't accept and take responsibility for their own decision to invest.

In a way I'm pleased to see that big black trade at the end today. The bid hasn't budged from 9.50 over the last two days, despite the increase in volume and ask price. I'm sure others have noticed the seller that's been active over the last couple of months. Big sells of hundreds of thousands of shares, almost daily that started when the SP was around 11p. On quiet days they just matched their sells with the fifty thousand buys etc. They have been very careful not to crash the SP. Over the last two days I reckon they have sold a million or so shares. That 4200000 is not the usual round number, and gives me hope that they are finally finished.

I've been contemplating who it could be for a while. It's someone with millions of shares, 5 million if not more. Maybe an ex Director? Wouldn't make sense if it was someone who bought in the recent raise, unless they suddenly found themselves in financial distress, but it's been too well managed for that.

Any thoughts?

Maybe different Biotech's evaluation different mAb's, with one having a premium over the other, or competing interest?

Mandeep Sehmi joined in September as Head of Business Development and may have changed evaluation conditions/requirements/negotiations?

Oh, so we should just tolerate a troll? The can stay childish while the rest have to grow up? If you post on a public BB then you have to accept the responses.

Per*

Violin,

As pre Berm's post at 7:48, they have only ever mentioned taking one mAb into clinic, SC134. The rest are open to deals at any time.